The Press Release Is On The Blog:
Telaprevir FDA Submission Complete Seeking Approval Asking For Priority Review
This drug will bring hope to friends, family and over 300 million chronic carriers of hepatitis C worldwide. It is happening folks, the progression of liver disease and damage stops here. Think of what this means; the chance of SVR after or before liver transplantation, hope for individuals with liver damage, F-3, cirrhosis, or genotype 1, hope, life.
.
The Big Picture, we dare to dream.....
The future of treating HCV with Telaprevir could mean....NO liver transplants, no pain, higher stats for achieving SVR for all , a cure!
I am so excited, so overwhelmed..........its a ground breaking day.
FAST TRACKED........ is the word of the day. Hope is the future.
Check Out The Press Release
,
This blog is all about current FDA approved drugs to treat the hepatitis C virus (HCV) with a focus on treating HCV according to genotype, using information extracted from peer-reviewed journals, liver meetings/conferences, and interactive learning activities.
Risk Of Developing Liver Cancer After HCV Treatment
- Home
- Newly Diagnosed With Hep C? Or Considering Treatment?
- All FDA Approved Drugs To Treat Hepatitis C
- Hepatitis C Genotypes and Treatment
- Mavyret (glecaprevir/pibrentasvir)
- Vosevi (Sofosbuvir/Velpatasvir/Voxilaprevir)
- Epclusa® (Sofosbuvir/Velpatasvir)
- Harvoni® (Ledipasvir/Sofosbuvir)
- VIEKIRA XR/VIEKIRA Pak
- Zepatier(Elbasvir/Grazoprevir)
- Cure - Achieving sustained virologic response (SVR) in hepatitis C
- HCV Liver Fibrosis
- FibroScan® Understanding The Results
- HCV Cirrhosis
- Staging Cirrhosis
- HCV Liver Cancer
- Risk Of Developing Liver Cancer After HCV Treatment
- Treating Elderly HCV Patients
- Fatty Liver Disease: NAFLD/NASH
- Current research articles on ailments that may be related to HCV
- Is There A Natural Way To Improve Liver Fibrosis?
- Can Food Or Herbs Interact With Conventional Medical Treatments?
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment